vitamin D


Episode 312: PREMIUM – 4 new studies that you need to know about

In episode 312, Mike and James give you PREMIUM information on high dose Vit D, delayed antibiotics, spironolactone and pioglitazone. All this new evidence supports pretty much all the premium stuff we’ve been saying for years – thank goodness.

Show notes

1) Vitamin D

JAMA Intern Med 2016;176:175-83 Read more »

Episode 219: Shining a bright light on the Vitamin D evidence – Part III

In episode 219, Mike and James final get to the end of the Vitamin D trilogy by reviewing the data for fractures and falls, mortality and cancer. At the end they identify that the best thing one can do when it comes to Vitamin D is to stand in the sun in a speedo bathing suit and eat mackerel – however the authorities intervene before that actually happened. Read more »

Episode 218: Shining a bright light on the Vitamin D evidence – Part II

In episode 218, Mike and James give you more and more Vitamin D love. We look at Vitamin D for MS, depression and upper respiratory tract infections and basically Vitamin D does nothing for these conditions - so go forth and share the love – which means not recommending Vitamin D for these conditions.

Show notes

1) The Calcium and Vitamin “Bible” Read more »

Episode 203: PREMIUM – Vitamin D, chelation therapy, and obesity studies you need to know about

In episode 203, James and Mike go all PREMIUM and discuss three new studies. Vitamin D for the common cold, chelation therapy post-MI and the link between obesity and mortality. If you are reading this and you are a non-PREMIUM member, boy are you missing something.

 Show notes

1) Vitamin D for the cold Read more »

Episode 194: The evidence for Vitamin D and folic acid for depression is not all that depressing

In episode 194, Mike and James invite our good friend and colleague David Gardner to layout the evidence for folic acid and Vitamin D for depression. Because there isn’t a lot of definitive evidence we discuss how to make recommendations in the face of limited evidence. We decide that decisions often come down to the chance of harm and what other alternatives are available. Read more »

Episode 148: Definitively vague questions with vaguely definitive answers - PART II

In episode 148, Mike and James return to the town of Questionville and attempt to answer riddles from near and far. Despite Mike having a cold, we tackle long acting insulins, exercise, multivitamins and varenecline with near Herculean-like abilities but provide answers that are much more on the mere-mortal side.

Show notes

1) Long acting insulins Read more »

Episode 111: PREMIUM – New stuff you really need to know about

In episode 111, Mike and James bring you the premier edition of the new PREMIUM TEC podcast episodes. We discuss high dose versus low dose statins, we possibly put the final nail in the rosiglitazone coffin and finally report that single high annual doses of Vitamin D didn’t do what they were supposed to do. Read more »

Episode 73: Vitamin D - dose, diet and dermatologists - Part II

In episode 73, we try to put Vitamin D levels into context and Tina Korownyk once again is here to help us decipher the evidence for Vitamin D supplementation when it comes to fractures, falls and overall mortality. Read more »

Episode 72: WE’RE BACK with Vitamin D, vim, and vigor

In episode 72, we find out what Mike has really been doing for the last 3 months by testing his Vitamin D level and finding it to be abnormally high. This leads us, along with our always charming guest Dr. Tina Korownyk, to a discussion of the proper use of Vitamin D levels and what they really mean. Read more »

Episode 18: Osteoporosis: The Initial Approach to Bone-Density

In episode 18 we consider the approach to questions of bone density and fracture risk. We use a series of cases to work through the risk of osteoporosis (using a simple tool) and help us decide on bone mineral density testing. We discuss initial options in the prevention of fractures including weight-bearing exercise, Calcium and Vitamin D (and its additional advantages). Read more »

Syndicate content